Cargando…

Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics

OBJECTIVE: This study aimed to investigate the clinical features of biologics-induced bullous pemphigoid (BP) and the therapeutic effects of those agents for BP, exploring the underlying pathophysiological mechanisms. METHODS: We searched PubMed, Web of Science, and Elsevier for studies involving pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jie, Wang, Si-Hang, Zuo, Ya-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849796/ https://www.ncbi.nlm.nih.gov/pubmed/36685489 http://dx.doi.org/10.3389/fimmu.2022.1050373

Ejemplares similares

Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Wang, Si-Hang, et al.
Publicado: (2021)

Biological treatment for bullous pemphigoid
por: Oren-Shabtai, Meital, et al.
Publicado: (2023)

Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types
por: Yan, Tianmeng, et al.
Publicado: (2023)

Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study
por: Wang, Si-Hang, et al.
Publicado: (2023)

Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid
por: Koga, Hiroshi, et al.
Publicado: (2023)

Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid
por: Zhang, Xiaoyan, et al.
Publicado: (2021)

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)

Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid
por: Tabatabaei-Panah, Pardis-Sadat, et al.
Publicado: (2019)

Case Report: The many faces of bullous pemphigoid
por: Rechtien, Laura, et al.
Publicado: (2023)

Case report: Successful treatment of non-bullous lichen planus pemphigoides with dupilumab
por: Li, Si-Zhe, et al.
Publicado: (2022)

The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury
por: Fang, Hui, et al.
Publicado: (2018)

Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Zhang, Yihua, et al.
Publicado: (2021)

Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review
por: Xie, Ying-Han, et al.
Publicado: (2022)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

Polymorphisms in the Mitochondrial Genome Are Associated With Bullous Pemphigoid in Germans
por: Russlies, Juliane, et al.
Publicado: (2019)

Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid
por: Zhou, Tong, et al.
Publicado: (2021)

Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
por: Rosi-Schumacher, Mattie, et al.
Publicado: (2023)

Comorbidity in bullous pemphigoid: up-date and clinical implications
por: Huttelmaier, Johanna, et al.
Publicado: (2023)

Adaptive and innate immune pathogenesis of bullous pemphigoid: A review
por: Yan, Tianmeng, et al.
Publicado: (2023)

Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid
por: Chen, Jia, et al.
Publicado: (2020)

Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019)

Thymic Stromal Lymphopoietin Is Implicated in the Pathogenesis of Bullous Pemphigoid by Dendritic Cells
por: Li, Si-Zhe, et al.
Publicado: (2020)

The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
por: Messingham, Kelly N., et al.
Publicado: (2019)

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021)

Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms
por: Cole, Connor, et al.
Publicado: (2022)

Pembrolizumab-induced bullous pemphigoid
por: Sun, Christina W., et al.
Publicado: (2019)

A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy
por: Guan, Shasha, et al.
Publicado: (2023)

Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)

Commentary: Proinflammatory role of blister fluid-derived exosomes in bullous pemphigoid
por: Liu, Yangchun, et al.
Publicado: (2020)

Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid
por: Fenne, Inger Johanne, et al.
Publicado: (2023)

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
por: Cao, Peng, et al.
Publicado: (2022)

Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy
por: Zhang, Luyao, et al.
Publicado: (2023)

Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid
por: Wang, Jianglin, et al.
Publicado: (2023)

Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019)

Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid
por: Riani, Meriem, et al.
Publicado: (2019)

Resolution in bullous pemphigoid
por: Sadik, Christian D., et al.
Publicado: (2019)

Esophageal Bullous Pemphigoid
por: Castelo Branco, Catarina, et al.
Publicado: (2022)

Dyshidrosiform Bullous Pemphigoid
por: Cohen, Philip R.
Publicado: (2021)

Cutaneous Dermatophytosis Mimicking Bullous Pemphigoid or Typical Bullous Pemphigoid and Tinea Incognito?
por: Andrés, Tirado-Sánchez, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fkidshsm36obv8lki6qsn80bf3